All In Biotech

Drug Trial Radar · NCT00516854

A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled Study

Last checked: Nov 20, 2026Latest source record: Jul 7, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Jun 2002

Primary completion

Not stated

Study completion Dec 2008

Sponsor

Lead sponsor
Hospital Authority, Hong KongGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
The University of Hong Kong
First posted
Aug 16, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Non-cardiac chest pain is a common clinical problem encountered in our practice but at present, the results of treatments are unsatisfactory. The pathogenesis remains unknown but altered motility of the esophagus and psychological factors including anxiety have been implicated as important factors. Reports of the single use of anticholinergic drugs and anxiolytics have yielded conflicting results, has been demonstrated to yield marginal or of no value. However the use of the combination therapy, especially with a double blind fashion have not been reported. On that basis, we propose to use a combination of anti-cholinergic and tranquilliser for the symptomatic treatment of non-cardiac chest pain. The aim of this study is to evaluate the efficacy of combination therapy of anti-cholinergic and anxiolytic drugs in the treatment of non-cardiac chest pain.

Conditions

  • Chest Pain

Interventions

  • chlordiazepoxide 5 mg, clidinium 2.5 mg, twice dailyDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Symptoms scores, quality of lifeTime frame: 12 Weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Queen Mary Hospital

    Hong Kong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.